Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Kiora Pharmaceuticals Ended Q2 With $20.7M In Cash, Cash Equivalents And Short-term Investments, Along With $2.4M In Collaboration Receivables And $0.7M In Research Incentive Tax Credits, With Projected Cash Runway Into Late 2027

Author: Benzinga Newsdesk | August 08, 2025 06:17am

Posted In: KPRX